DCGO
Company Description
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 322.20M | 616.56M | 624.29M | 440.52M | 318.72M | 94.09M | 48.30M |
| Net Income | (182.40M) | 19.99M | 6.86M | 34.58M | 23.74M | (14.36M) | (20.21M) |
| EPS | -1.84 | 0.20 | 0.07 | 0.34 | 0.30 | -0.14 | -0.20 |
| Free Cash Flow | 27.02M | 64.50M | (74.35M) | 23.37M | (8.60M) | (16.97M) | (18.01M) |
| FCF / Share | 0.27 | 0.63 | -0.72 | 0.23 | -0.11 | -0.17 | -0.18 |
| Operating CF | 34.45M | 70.34M | (64.22M) | 28.87M | (1.95M) | (10.65M) | (14.21M) |
| Total Assets | 217.10M | 455.62M | 490.45M | 393.28M | 309.60M | 100.17M | 100.96M |
| Total Debt | 29.18M | 57.19M | 46.50M | 19.91M | 16.51M | 13.89M | 15.54M |
| Cash & Equiv | 51.02M | 89.24M | 59.29M | 157.34M | 175.54M | 32.42M | 47.74M |
| Book Value | 144.01M | 320.92M | 300.79M | 273.23M | 219.58M | 55.00M | 68.47M |
| Return on Equity | -1.27 | 0.06 | 0.02 | 0.13 | 0.11 | -0.26 | -0.30 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.55M | 74.94M | 70.81M | 80.42M | 96.03M | 120.83M | 138.68M | 164.95M | 192.09M | 199.25M | 186.55M | 125.49M |
| Net Income | (14.76M) | (134.07M) | (27.77M) | (11.16M) | (9.41M) | (3.26M) | 5.50M | 6.53M | 11.23M | 7.57M | 4.76M | (2.01M) |
| EPS | -0.15 | -1.37 | -0.28 | -0.11 | -0.09 | -0.03 | 0.05 | 0.06 | 0.11 | 0.07 | 0.05 | -0.02 |
| Free Cash Flow | (5.09T) | (12.60M) | 101,163 | 32.04M | 7.47M | 12.22M | 29.59M | 35.06M | (12.36M) | (9.21M) | (47.23M) | 8.58M |
| FCF / Share | -51527.32 | -0.13 | 0.00 | 0.32 | 0.07 | 0.12 | 0.29 | 0.34 | -0.12 | -0.09 | -0.45 | 0.08 |
| Operating CF | (4.66T) | (10.47M) | 1.66M | 33.60M | 9.66M | 12.89M | 31.03M | 37.06M | (10.64M) | (5.92M) | (45.88M) | 10.69M |
| Total Assets | 209.23M | 217.10M | 353.78M | 408.26M | 430.79M | 455.62M | 493.88M | 488.17M | 490.69M | 490.45M | 419.78M | 390.29M |
| Total Debt | 28.51M | 29.18M | 29.46M | 60.45M | 60.86M | 57.19M | 56.99M | 53.21M | 52.20M | 46.50M | 21.16M | 20.56M |
| Cash & Equiv | 35.68M | 51.02M | 73.36M | 104.16M | 79.01M | 89.24M | 89.46M | 66.06M | 41.24M | 59.29M | 52.92M | 109.16M |
| Book Value | 132.31M | 144.01M | 270.53M | 297.28M | 309.34M | 320.92M | 325.21M | 315.16M | 311.32M | 300.79M | 287.60M | 279.77M |
| Return on Equity | -0.11 | -0.93 | -0.10 | -0.04 | -0.03 | -0.01 | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | -0.01 |
